MOTS-c and HSA/FSA Eligibility: What the Rules Actually Establish
Why the payment method does not answer the question
HSA and health FSA funds receive favorable tax treatment when used under the applicable rules. The transaction itself is not the final test. A card processor may accept a charge without evaluating the identity of every item or the legal basis for supplying it.
IRS Publication 969 describes qualified medical expenses and the rules for these accounts. Publication 502 explains medical-expense concepts and exclusions, including illegal treatments. The documents serve different purposes and should be read together where relevant. [1,2]
What a letter of medical necessity proves
A letter can document a clinician's reasoning about an expense and a diagnosed condition. It does not turn a research compound into an approved drug, create a compounding exception, or bind an administrator to reimburse the charge.
The same limit applies to an itemized receipt. It can document a transaction, date, and amount. Those are useful accounting facts, but they do not independently establish eligibility. Adding a diagnosis code or calling the purchase a metabolic-health program cannot replace the underlying requirements.
| Document or event | What it records | What it does not settle |
|---|---|---|
| Prescription | A prescriber's order | Whether the substance may be supplied through that pathway |
| Medical-necessity letter | A clinical rationale | Whether all tax and plan requirements are met |
| Pharmacy-style receipt | A stated purchase | Drug approval or lawful compoundability |
| Approved card transaction | Payment processing | A final qualified-expense determination |
MOTS-c research is not a reimbursement designation
The original 2015 MOTS-c paper investigated a mitochondrial-derived peptide using cellular and animal experiments related to metabolic regulation. It did not establish a reimbursable human treatment for fatigue, insulin resistance, or exercise recovery. [3]
FDA's compounding information also separates ingredient eligibility from the existence of a prescription. A biological mechanism and a clinician's interest do not together satisfy that framework. [4]
How HSA/FSA rules differ from the itemized deduction
One common source of confusion is over-the-counter medicine. Publication 969 recognizes qualifying over-the-counter medicines as account expenses without requiring a prescription. Publication 502's itemized-deduction discussion has different prescription requirements. Neither rule classifies MOTS-c as an over-the-counter medicine. [1,2]
This matters because a general article about eligible supplements or medicines can be incorrectly reused as proof for a particular peptide. Eligibility needs analysis of the actual expense, not just the category used in an advertisement.
Frequently asked questions
Does a clinic saying “HSA accepted” mean MOTS-c qualifies?
No. Acceptance of a payment method does not establish the eligibility of every item sold by that business.
Can a letter guarantee reimbursement?
No. Its supporting role is limited by the governing rules and the plan's terms. A promised outcome before those questions are resolved is not a reliable eligibility determination.
Is this an argument that all compounded medicines are ineligible?
No. Different preparations have different legal and benefit circumstances. The issue here is the unsupported claim that documentation alone establishes MOTS-c eligibility.
